Eli Lilly is the clear leader in the burgeoning weight loss market. Its lineup and pipeline put it well ahead of even its ...

Weight-loss drugs known as GLP-1s are transforming health care. Some people who struggled for years to shed pounds experience ...

A major health care divide is coming in 2026. Some Americans may finally catch a break on rising costs, as the first ...

While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them ...

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. Trading was extremely light ...

The era of "oral obesity drugs" has officially begun as Danish pharmaceutical company Novo Nordisk’s obesity treatment received U.S. Food and Drug Administration (FDA) approval in pill form. This is ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The Standard & Poor’s 500 index rose 22.26 points, or 0.3%, to 6,932.05. The Dow Jones industrial ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The S&P 500 index rose 22.26 ...

TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite ...